Pasithea Therapeutics receives Nasdaq minimum bid price non-compliance notice

Pasithea Therapeutics Corp.

Nasdaq notified company on June 23, 2025 that common stock bid price closed below $1.00 for 30 consecutive business days.
Company has 180 calendar days, until December 22, 2025, to regain compliance by closing at $1.00+ for 10 consecutive days.
If not cured, company may qualify for an additional 180-day period if it meets other listing requirements and intends to effect a reverse stock split.
Company is evaluating options; notice does not affect business operations or SEC reporting obligations.

item 3.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.